The vector of anti-CD30 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD30. The T cells are genetically modified through transduction with a retroviral vector expressing scFv of anti-CD30 antibody linked to TCRζ signaling domains. And the vector product was designed for the treatment of Hodgkin disease.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-CAR-LC489||Lenti-CD30 CAR (scFv-CD28-CD3ζ, BerH2) Viral Particle|
|VP-CAR-LC488||Lenti-CD30 CAR (scFv-CD28-FcεRIγ, BerH2) Viral Particle|
|VP-CAR-LC496||Lenti-CD30 CAR (scFv-CD28-OX40-CD3ζ, BerH2) Viral Particle|
|VP-CAR-LC490||Lenti-CD30 CAR (scFv-CD4-FcεRIγ, BerH2) Viral Particle|
|VP-CAR-LC491||Lenti-CD30 CAR (scFv-CD4-CD3ζ, BerH2) Viral Particle|
|OAdCmodV-YX2148||Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ19k, Anti-TNFRSF8), Viral particle|
|CAR-MZ064||Anti-CD30 (HRS3) h(OX40-CD3ζ) CAR, pCDCAR1|
|CAR-LC060||Anti-CD30 (Brentuximab) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-T-2-M301-BZ||Anti-CD30 scFv h(41BB-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC485||Lenti-CD30 CAR (scFv-CD28, BerH2) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved